Transcriptomics

Dataset Information

0

Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA


ABSTRACT: Expressed on cells of the myeloid and lymphoid lineages, V-domain Ig Suppressor of T cell Activation (VISTA) is an emerging target for cancer immunotherapy. Blocking VISTA activates both innate and adaptive immunity to eradicate tumors in mice. Using a tripeptide small molecule antagonist of VISTA CA170, we found that it exhibited potent anticancer efficacy on carcinogen-induced mouse lung tumorigenesis. Remarkably, lung tumor development was almost completely suppressed when CA170 was combined with an MHCII-directed Kras peptide vaccine. Flow cytometry and single-cell RNA sequencing (scRNA-seq) revealed that CA170 increased CD8+ T cell infiltration and enhanced their effector functions by decreasing the tumor infiltration of myeloid-derived suppressor cells (MDSCs) and Regulatory T (Treg) cells, while the Kras vaccine primarily induced expansion of CD4+ effector T cells. VISTA antagonism by CA170 revealed strong efficacy against lung tumorigenesis with broad immunoregulatory functions that influence effector, memory and regulatory T cells, and drives an adaptive T cell tumor-specific immune response that enhances the efficacy of the Kras vaccine.

ORGANISM(S): Mus musculus

PROVIDER: GSE176091 | GEO | 2021/06/04

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2022-12-02 | E-MTAB-10856 | biostudies-arrayexpress
2022-06-26 | GSE206835 | GEO
2024-10-17 | PXD050084 | Pride
2020-09-05 | GSE157518 | GEO
2021-05-04 | GSE173747 | GEO
2021-08-04 | GSE181163 | GEO
2024-01-02 | GSE244545 | GEO
2024-01-02 | GSE244797 | GEO
2015-02-05 | E-GEOD-52798 | biostudies-arrayexpress
| PRJNA852275 | ENA